Stella Xu - 01 Jul 2021 Form 4/A - Amendment Insider Report for Tempest Therapeutics, Inc. (TPST)

Reporting relationship: Director
Issuer ticker: TPST
Reported as of: 01 Jul 2021
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 20 Sep 2021, 20:10:08 UTC
Original report date: 06 Jul 2021
Prior SEC filing: 29 Jun 2021
Next SEC filing: 22 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Pierre Lorenzo (Attorney-in-Fact)

Key filing fact

Stella Xu filed Form 4/A - Amendment for Tempest Therapeutics, Inc. (TPST) on 20 Sep 2021.

Key facts

This page summarizes Stella Xu's Form 4/A - Amendment filing for Tempest Therapeutics, Inc. (TPST).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Sep 2021, 20:10.

Change

Previous filing in this sequence was filed on 29 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TPST transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +6,635
Change %
Price: $0.000000
Shares after: 6,635
Date: 01 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,635
Exercise price: $11.07
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Vests over three (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.

Footnote F2

The reporting person holds these securities for the benefit of Quan Venture Fund I, L.P. ("Quan Capital"). The general partner of Quan Capital is Quan Venture Partners I, L.L.C. The reporting person is amanager of Quan Venture Partners I, L.L.C. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest. This report on Form 4 shall not be deemed anadmission the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

SEC remarks

The amended Form 4 is being filed to correct the vesting schedule of the option grant and to correct the price of the derivative security.